Axonics Inc
(FRA:0I3)
€
61
0 (0%)
Market Cap: 3.29 Bil
Enterprise Value: 3.00 Bil
PE Ratio: 0
PB Ratio: 5.57
GF Score: 84/100 Axonics Inc at Bank of America Healthcare Conference Transcript
May 10, 2022 / 04:20PM GMT
Release Date Price:
€44.6
Travis Lee Steed
BofA Securities, Research Division - MD
Good morning, everybody. I am Travis Steed, the medical device analyst at BofA, and we're thrilled to have Axonics here this morning. We've got both Ray Cohen, CEO; and Dan Dearen, CFO. Welcome.
Raymond W. Cohen
Axonics, Inc. - CEO & Director
Thank you.
Questions & Answers
Travis Lee Steed
BofA Securities, Research Division - MD
So I just wanted to start off, think through the kind of 1 recovery. I know you had a new product line, so it kind of masks some of that to some degree. So if you think about just looking at your rechargeable device and not the new product, F15, and think about January, February to March and that recovery in March and then -- and how that's kind of improved through April and even into May, does that continue to progress nicely month-to-month?
Raymond W. Cohen;Travis Lee Steed
Axonics, Inc. - CEO & Director;BofA
Sure. So January was...
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot